Latest: Q3 2026 · from the cash-flow statements filed with the SEC
Free cash flow−$196M in Q3 2026 · $238M over twelve months
Operating cash flow−$159M
Capital spending−$37.0M
Free cash flow−$196M
Cash / net income-4.2×
Cash conversion cycle17 days
Analysis
In Q3 2026, Molina Healthcare generated −$159M of operating cash flow and spent $37.0M on capital projects, leaving free cash flow of −$196M. That is $33.0M less than in Q3 2025 (−$163M).
Over the twelve months to Sep 30, 2026, operating cash flow was $331M; the largest uses were net borrowing (+) / repaid (−) ($740M), capital spending ($93.0M), other investing ($5.0M); besides operations, cash came from other financing ($801M); the cash balance rose by $294M.
Operating cash flow was −$159M against net income of $38.0M — -4.2× profit, less cash than reported earnings, worth checking against working capital. The largest differences: receivables +$126M, depreciation & amortization +$38.0M, income taxes payable −$29.0M.
Its cash conversion cycle was 17 days (receivables 28 + inventory 0 − payables 11).
Free cash flow
Operating cash flow less capital spending.Latest (Q3 2026): Operating cash flow −$159M, Capital spending $37.0M.
Capital allocation, year by year
Over these 5 years operating cash flow totalled $4.7B; the largest uses were buybacks ($2.5B) and acquisitions ($855M). Cash-flow statements as filed.
Cash runway and the debt wall
Cash & investments$8.6B
Debt$3.8B
Net cash$4.8B
Cash runwaymore than 10 years
Molina Healthcare is burning cash: its operations consume cash, a free cash flow of −$784M a year at the current rate against $8.6B of cash and investments: a runway of more than ten years at that rate before any new financing.
Principal due in each year as disclosed in the annual report, against $8.6B of cash and investments now.
Where the cash came from and went
From profit to cash
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
Quarter
Receivable days
Inventory days
Payable days
Cash conversion cycle
Q3 2026
28
—
11
17
Q2 2026
29
—
11
18
Q1 2026
29
—
11
18
Q4 2025
29
—
10
18
Q3 2025
30
—
10
19
Q2 2025
29
—
10
19
Q1 2025
27
—
12
16
Q4 2024
29
—
13
16
Every quarter
Quarter
Operating cash flow
Capital spending
Acquisitions
Buybacks
Net borrowing (+) / repaid (−)
Cash drawn (+) / kept (−)
Free cash flow
Q3 2026
−$159M
−$37.0M
—
—
—
$475M
−$196M
Q2 2026
−$294M
−$30.0M
—
—
—
$328M
−$324M
Q1 2026
$1.1B
−$27.0M
—
—
—
−$1.1B
$1.1B
Q4 2025
−$298M
$1.0M
—
—
−$740M
−$24.0M
−$297M
Q3 2025
−$125M
−$38.0M
—
−$500M
$290M
$268M
−$163M
Q2 2025
−$302M
−$42.0M
—
—
—
$363M
−$344M
Q1 2025
$190M
−$22.0M
−$245M
−$500M
$650M
−$214M
$168M
Q4 2024
−$224M
−$11.0M
—
−$500M
−$150M
$138M
−$235M
Molina Healthcare: income statement and cash flow
Molina Healthcare, Q3 2026: revenue $11.1B (-3% year over year), operating margin 1.0%. The chart follows the revenue to costs, profit and cash.
Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.